Thanks to its combination of clinical pharmacology and bioanalytical services, QPS Netherlands has broad experience in performing dose-escalating (first-in-man) and drug-drug interaction studies with rapid turnaround of time-sensitive PK and biomarker samples.

1. QPS IS YOUR GLOBAL LINK FROM CANDIDATE SELECTION TO
FIRST IN MAN

2. QPS is a highly competent, high-quality, yet cost effective and QPS NETHERLANDS
accessible CRO that goes above-and-beyond to build a trusting
Clinical Pharmacology Unit
relationship with you.
Please allow us to help save you valuable time and decrease the cost
of drug development by linking with QPS for the following suite of
global drug discovery and development services:
YOUR GLOBAL LINK TO DMPK & TOXICOLOGY SERVICES
Preclinical Services at our USA and Taiwan Facilities
High quality DMPK & Toxicology capabilities (full AAALAC Accreditation
since 2000)
Supported over 1000 GLP toxicology studies since 1997
YOUR GLOBAL LINK TO BIOANALYTICAL SERVICES
GLP Bioanalytical Facilities in the USA, Europe, India and Taiwan QPS Netherlands has its own state-of-the-art clinical pharmacology unit (CPU) with 34
beds, an advanced bioanalytical laboratory, GMP pharmacy, and a medical recruitment
One of the largest CROs in bioanalysis for small molecules and biologics
and examination center. The company is strategically located at the University Medical
Extensive list of validated assays; > 800 and growing Center Groningen (UMCG). The clinical pharmacology beds and bioanalytical laboratories
Chromatography & Mass Spectrometry (LC-MS/MS) are highly integrated, resulting in a very efficient operational environment. QPS Nether-
lands has several strategic partners that further support its operations. These strategic
Biochemistry & Immunology (ELISA, hybridization-ELISA)
partners include Dinox (www.dinoxgroup.com) - a CRO specializing in female healthcare;
Elemental Spectrometry (ICP-MS) and many clinical specialists from the UMCG. Cooperation with these strategic partners
gives QPS Netherlands a clear competitive advantage in specific therapeutic fields such as
Female Health Care, CNS, Pain and Pulmonary Medicine. Key customers include several
YOUR GLOBAL LINK TO TRANSLATIONAL MEDICINE SERVICES global top-10 pharmaceutical companies and all of the global top-5 biotechnology
Specialized biomarker assay capabilities in various niche areas companies. Numerous small and medium-sized pharmaceutical and biotechnology
Assistance with selection and evaluation of the right biomarkers during companies complete QPS Netherlands’ customer base. Projects at QPS Netherlands range
early drug development from full-service phase I/IIa drug development, including strategic consultancy, to
dedicated single task projects with high value added.
Molecular biology/genomic services including RNA/DNA isolation; SNP
genotyping and genetic mutation analysis; quantitative RT-PCR; RNA Thanks to its highly integrated combination of clinical pharmacology and bioanalytical
services, QPS Netherlands has broad experience in performing dose-escalating (first-in-
expression analysis; and microarray gene expression profiling man) and drug-drug interaction studies with rapid turnaround of time-sensitive PK and
biomarker samples.
YOUR GLOBAL LINK TO EARLY STAGE CLINICAL RESEARCH SERVICES
Over 400 phase I beds in the USA, Europe, India, and Taiwan; one of the SPECIALITIES:
best and largest phase I site offerings in the world catering both to the First-in-man studies
needs of the innovative and the generic pharmaceutical industries CNS (including experience with continuous CSF sampling after lumbar puncture)
Highly experienced, flexible and customer-focus phase I units leading to Pain (validated models for acute and chronic pain)
better efficiency and quality during the conduct of your early stage
clinical trials Pulmonary Medicine
Imaging (PET, fMRI)
YOUR GLOBAL LINK TO LATE STAGE CLINICAL RESEARCH SERVICES Human Mass Balance
Worldwide contract clinical staffing and pharmacometrics capabilities Female Health Care
(incl. data management, biostatistics, PK/PD evaluation and medical
writing capabilities) that will expedite your next development milestone Should you want to discuss your questions in more detail with one of our experts, please
ahead of schedule contact us directly at: info@qps.com
Corporate Office
Delaware Technology Park, 3 Innovation Way, Suite 240, Newark, DE 19711
www.qps.com
Email: info@qps.com TEL: + 1 302 369 5601 FAX: + 1 302 369 5602
2012 QPS Holdings. All Rights Reserved